logo
  

Electrolux Q1 Profit Down, Sales Rise - Quick Facts

Swedish home appliances giant Electrolux AB (0MDT.L,0GQ1.L,ELUXY.PK) reported Friday that its first-quarter income declined 39 percent to 950 million Swedish kronor from last year's 1.56 billion kronor.

Earnings per share were 3.40 kronor, 37 percent lower than 5.41 kronor a year ago.

Operating income declined 31 percent to 1.58 billion kronor, and operating margin fell to 5.2% from 7.9% in the prior year.

Net sales, however, increased to 30.12 billion kronor from last year's 29.03 billion kronor. Organic sales declined 3.4% due to lower volumes compared to a strong last year, partially offset by strong price execution.

Looking ahead for the full year, the company said it remains confident that price will fully offset cost inflation, as it has done for the past four years.

Further, the company revised regional market demand outlook for the 2022 full year in North America, mainly driven by supply constraints, and in Europe, due to lower consumer confidence. However, the company still expects demand in these regions to be above pre-pandemic levels.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT